Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
Route 92 Medical is a medical device company developing a catheter to treat stroke.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.
SUBRA A/S focuses on innovation, industrial-scale production, and creating a sustainable impact.
Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.
Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Aquafortus is a non-thermal recovery and crystallization technology platform.
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Nalu Medical is a medical technology company that offers neurostimulation system designed to treat chronic nerve pain.
Phasecraft develops quantum algorithms and related intellectual property for scientific and industrial applications.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Medical, Biopharma, Therapeutics. The firm invests across 22 different industry categories.
Among tracked funding rounds, MapLight Therapeutics received $372.5M in a Series D round. Novo Holdings's total known invested capital is $15.2B.
Novo Holdings's average investment size is $84.4M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include Invetx, Route 92 Medical, Coultreon Biopharma, Ray Therapeutics, Spruce Biosciences. These companies were founded in 2020 or later.